134 related articles for article (PubMed ID: 30747671)
1. Long-Term Outcomes after Elective
Manguso N; Gangi A; Nissen N; Harit A; Siegel E; Hendifar A; Amersi F
Am Surg; 2018 Oct; 84(10):1570-1574. PubMed ID: 30747671
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
4. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
[TBL] [Abstract][Full Text] [Related]
6. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.
Howe JR; Cardona K; Fraker DL; Kebebew E; Untch BR; Wang YZ; Law CH; Liu EH; Kim MK; Menda Y; Morse BG; Bergsland EK; Strosberg JR; Nakakura EK; Pommier RF
Pancreas; 2017 Jul; 46(6):715-731. PubMed ID: 28609357
[TBL] [Abstract][Full Text] [Related]
7. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
[TBL] [Abstract][Full Text] [Related]
10. The Distal Predilection of Small Bowel Neuroendocrine Tumors.
Keck KJ; Maxwell JE; Utria AF; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2018 Oct; 25(11):3207-3213. PubMed ID: 30054825
[TBL] [Abstract][Full Text] [Related]
11. Surgery for small-bowel neuroendocrine tumors: is there any benefit of the laparoscopic approach?
Figueiredo MN; Maggiori L; Gaujoux S; Couvelard A; Guedj N; Ruszniewski P; Panis Y
Surg Endosc; 2014 May; 28(5):1720-6. PubMed ID: 24380996
[TBL] [Abstract][Full Text] [Related]
12. Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.
Ethun CG; Postlewait LM; Baptiste GG; McInnis MR; Cardona K; Russell MC; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Nov; 114(6):671-676. PubMed ID: 27511436
[TBL] [Abstract][Full Text] [Related]
13. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
14. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
15. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
16. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
18. It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors.
Tran CG; Sherman SK; Scott AT; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2021 Feb; 28(2):732-741. PubMed ID: 32656719
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: A retrospective study in China.
Zhang S; Zheng C; Chen Y; Xu Q; Ma J; Yuan W; Jiang Q; Zhao Y; Zhang J; Che X; Wang C; Huang X; Chen F; Wang N; Ma X; Lan Z
Int J Surg; 2017 Jul; 43():145-154. PubMed ID: 28583893
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort.
Bösch F; Bruewer K; D'Anastasi M; Ilhan H; Knoesel T; Pratschke S; Thomas M; Rentsch M; Guba M; Werner J; Angele MK
Surgery; 2018 Nov; 164(5):1093-1099. PubMed ID: 30076029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
